Transition From Inhaled to Parenteral Treprostinil in Selected Patients With Pulmonary Arterial Hypertension
Chest(2011)
摘要
PURPOSE: Treprostinil is a prostacyclin analog available in inhaled, subcutaneous and intravenous forms. This study investigated the rationale, safety, and tolerability of transition from inhaled to parenteral treprostinil in pulmonary arterial hypertension (PAH).
更多查看译文
关键词
parenteral treprostinil,pulmonary arterial hypertension,inhaled,arterial hypertension
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要